Related Experiment Video
Updated: Jul 16, 2025

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Topical Diclofenac to Manage Opioid-Refractory Pain in a Rare Pancreatic Fibrosarcoma
Syed H Ali1, Tyler Jorgensen1,2, Rohit K Prasad3
1Department of Medicine and University of Texas at Austin Dell Medical School, Austin, Texas, USA.
Abstract:
Pancreatic cancer is often diagnosed at an advanced stage and is frequently associated with severe pain. Traditional pain management in this condition may be improved with the use of topical diclofenac. A 39-year-old man with advanced pancreatic fibrosarcoma metastatic to the thoracic spine presented to the hospital with severe abdominal pain refractory to escalating doses of opioids. A celiac plexus block produced significant, yet inadequate, pain reduction. Satisfactory pain control and opioid de-escalation were ultimately achieved with the application of topical diclofenac gel to an area of bony metastasis. This case illustrates the potential for pain control using topical diclofenac in patients with pancreatic soft tissue tumors and vertebral metastases. Topical diclofenac may exert antitumoral effects and targeted application may improve absorption, leading to improved pain control. The use of topical diclofenac for pain management in metastatic pancreatic cancer presents an interesting tool that should be considered in similar cases.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Acute Pancreatitis II: Clinical Manifestations and Management
Peripheral Artery Disease V: Postoperative Nursing Management

